Skip to Main Content

Paper Details

Management of hormone receptor-positive, HER2-negative early breast cancer.
Seminars in Oncology
16
2020
HER2, HR, breast cancer, breast cancers, early breast cancer, hormone receptor, human epidermal growth factor receptor 2
Author NameAffiliation
Vered StearnsSidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine
  • 1 - 1

Datasets

Release 1.2